SARS-CoV-2 Vaccine Effectiveness against Omicron Variant in Infection-Naive Population, Australia, 2022article Published on 2023-06-012024-09-05 Journal: Emerging Infectious Diseases [Category] update2024, [키워드] 2019 novel coronavirus disease Australia coronavirus disease COVID-19 omicron respiratory infections SARS-CoV-2 SARS-CoV-2–naive severe acute respiratory syndrome coronavirus 2 vaccine effectiveness viruses zoonoses [DOI] 10.3201/eid2906.230130 PMC 바로가기 [Article Type] article
Interim 2022/23 influenza vaccine effectiveness: six European studies, October 2022 to January 2023article Published on 2023-05-252024-09-05 Journal: Eurosurveillance [Category] update2024, [키워드] Europe Influenza multicentre study test-negative design vaccine effectiveness [DOI] 10.2807/1560-7917.ES.2023.28.21.2300116 PMC 바로가기 [Article Type] article
Effectiveness of COVID-19 Vaccines at Preventing Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompromised Adults: An Observational Study of Real-World Data Across 10 US States from August-December 2021Article Published on 2023-05-222024-09-05 Journal: Vaccine [Category] update2024, [키워드] COVID-19 Hospitalization Immunocompromised mRNA vaccines vaccine effectiveness [DOI] 10.1016/j.vaccine.2023.05.038 PMC 바로가기 [Article Type] Article
BNT162b2 Effectiveness Against Delta and Omicron Variants of Severe Acute Respiratory Syndrome Coronavirus 2 in Adolescents Aged 12–17 Years, by Dosing Interval and DurationMajor Article Published on 2023-05-012024-09-05 Journal: Nanoscale [Category] update2024, [키워드] adolescents BNT162b2 booster dose COVID-19 vaccine SARS-CoV-2 test-negative design vaccine effectiveness variants of concern [DOI] 10.1093/infdis/jiad006 PMC 바로가기 [Article Type] Major Article
Effectiveness of the COVID-19 vaccines on preventing symptomatic SARS-CoV-2 infections and hospitalizations in Southwestern Alaska, January–December 2021Article Published on 2023-05-012024-09-05 Journal: Vaccine [Category] update2024, [키워드] Alaska Native people American Indian People Hospitalization SARS-CoV-2 vaccine effectiveness [DOI] 10.1016/j.vaccine.2023.04.070 PMC 바로가기 [Article Type] Article
Vaccine effectiveness of primary and booster COVID-19 vaccinations against SARS-CoV-2 infection in the Netherlands from July 12, 2021 to June 6, 2022: A prospective cohort studyArticle Published on 2023-04-202024-09-05 Journal: International Journal of Infectious Diseases [Category] update2024, [키워드] COVID-19 SARS-CoV-2 vaccine effectiveness [DOI] 10.1016/j.ijid.2023.04.401 PMC 바로가기 [Article Type] Article
Influenza vaccine effectiveness in patients hospitalized with severe acute respiratory infection in Lithuania during the 2019-2020 influenza season: a test negative case – control studyArticle Published on 2023-04-122023-06-24 Journal: Virology Journal [Category] 신종인플루엔자, [키워드] Hospital surveillance Influenza test-negative design vaccine effectiveness [DOI] 10.1186/s12985-023-02015-0 PMC 바로가기
Factors affecting the immunogenicity of influenza vaccines in humanArticle Published on 2023-04-062023-06-24 Journal: BMC Infectious Diseases [Category] 신종인플루엔자, [키워드] immune response immunogenicity Influenza influenza vaccine vaccine effectiveness [DOI] 10.1186/s12879-023-08158-3 PMC 바로가기
Vaccine effectiveness against transmission of alpha, delta and omicron SARS-COV-2-infection, Belgian contact tracing, 2021–2022Article Published on 2023-04-052024-09-05 Journal: Vaccine [Category] update2024, [키워드] Alpha Variant of Concern Delta variant of concern Infection-acquired immunity infectiousness mRNA-vaccine Omicron variant of concern SARS-CoV-2 susceptibility Transmission vaccine effectiveness Vaccine-induced immunity Viral-vector vaccine [DOI] 10.1016/j.vaccine.2023.03.069 PMC 바로가기 [Article Type] Article
SARS-CoV-2 Vaccine Effectiveness and Breakthrough Infections Among Patients Receiving Maintenance DialysisSARS-CoV-2 백신 효과 및 유지 투석을 받는 환자에서의 돌파 감염Observational Study Published on 2023-04-012023-07-10 Journal: American journal of kidney diseases : the official [Category] COVID19(2023년), [키워드] anti-Spike IgG Antibody titer Breakthrough infection Coronavirus disease 2019 (COVID-19) death delta variant End-stage renal disease (ESRD) Hospitalization Maintenance dialysis seroimmunity severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine effectiveness vaccine response [DOI] 10.1053/j.ajkd.2022.10.010 PMC 바로가기 [Article Type] Observational Study